- likes
- 34
- comments
- 1
Post
Patient-reported treatment tolerability is becoming an increasingly important part of regulatory and clinical decision-making. Learn how sponsors can capture the patient perspective, support benefit-risk assessments, and strengthen trial design. Download the white paper here: https://lnkd.in/eNRnbbsb